abrdn Medical Science Innovation Portfolio Series 9 Guggenheim Defined Portfolios Series 2454
$12.64
+0.16 (+1.28%)
NAV as of Oct 14, 2026
Performance
- 1 Month
- -8.2%
- 3 Months
- -7.3%
- YTD
- -0.1%
- 1 Year
- +17.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 25.5%
- Largest decline max drawdown, since Jan 2025
- -22.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.77
Own CTMEIX?
See how CTMEIX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.